Back to Search
CHARLES DEPRIEST, MD
MD
Diagnostic Radiology Physician
NPI: 1104911387Individual
Specialties, Licenses & Credentials
Research & Publications (18)
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
PMID 19538053·Cancer Biother Radiopharm·2009
8-other
Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
PMID 17600465·Cancer Biother Radiopharm·2007
3-trial
Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.
PMID 17651037·Cancer Biother Radiopharm·2007
8-other
Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09.
PMID 16706633·Cancer Biother Radiopharm·2006
3-trial
Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?
PMID 16114985·Cancer Biother Radiopharm·2005
8-other
Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.
PMID 15650459·Cancer Biother Radiopharm·2004
3-trial
Tumor-infiltrating lymphocytes and interleukin-2: dose and schedules of administration in the treatment of metastatic cancer.
PMID 15665620·Cancer Biother Radiopharm·2004
8-other
Phase I/II trial of autologous tumor cell line-derived vaccines for recurrent or metastatic sarcomas.
PMID 15650450·Cancer Biother Radiopharm·2004
3-trial
Autologous tumor cell line-derived vaccine for patient-specific treatment of advanced renal cell carcinoma.
PMID 15650449·Cancer Biother Radiopharm·2004
8-other
Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research group.
PMID 14629821·Cancer Biother Radiopharm·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 8 locations total
- Address
- 2009 Mallory Ln Ste 150
Franklin, TN 37067 - Phone
- (615) 771-8668
Locations (8)
Practice Location
2009 Mallory Ln Ste 150, Franklin, TN
(615) 771-8668
Practice Location
719 Thompson Ln Ste 23300, Nashville, TN
(615) 936-3606
Practice Location
4525 Harding Pike Ste 102, Nashville, TN
(615) 463-3034
Practice Location
337 22nd Ave N, Nashville, TN
(615) 327-1500
Practice Location
3601 TVC, NASHVILLE, TN
(615) 322-3000
Practice Location
1161 21ST AVE S, NASHVILLE, TN
(615) 343-1501
Practice Location
1909 ACKLEN AVE, NASHVILLE, TN
(615) 777-9729
Practice Location
210 25TH AVE N STE 1204, NASHVILLE, TN
(615) 312-0600
Quick Facts
- NPI
- 1104911387
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 8
- Publications
- 18
Are you this provider?
Claim Your Profile